Related references
Note: Only part of the references are listed.Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients
Marzia Ognibene et al.
CANCER BIOLOGY & THERAPY (2020)
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
Vito Alessandro Lasorsain et al.
NPJ GENOMIC MEDICINE (2020)
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
Daniel Martin et al.
NATURE COMMUNICATIONS (2018)
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann et al.
SCIENCE (2018)
Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone
M. Reza Abbasi et al.
CLINICAL CANCER RESEARCH (2017)
Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications
Xiaoyu Chen et al.
BIOINFORMATICS (2016)
Canvas: versatile and scalable detection of copy number variants
Eric Roller et al.
BIOINFORMATICS (2016)
Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells
Yohan Suryo Rahmanto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
Vito Alessandro Lasorsa et al.
ONCOTARGET (2016)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al.
NATURE GENETICS (2015)
Mutational dynamics between primary and relapse neuroblastomas
Alexander Schramm et al.
NATURE GENETICS (2015)
Germline Mutations in Predisposition Genes in Pediatric Cancer
Jinghui Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines
Britta Stolze et al.
SCIENTIFIC REPORTS (2015)
Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
Katherine K. Slemmons et al.
PLOS ONE (2015)
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
Gaurav Kumar Pandey et al.
CANCER CELL (2014)
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Gudrun Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Long-Term Results of the Combination of the N7 Induction Chemotherapy and the Busulfan-Melphalan High Dose Chemotherapy
Dominique Valteau-Couanet et al.
PEDIATRIC BLOOD & CANCER (2014)
Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
Weiying Zhang et al.
SCIENCE SIGNALING (2014)
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Helga Thorvaldsdottir et al.
BRIEFINGS IN BIOINFORMATICS (2013)
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Mark Sausen et al.
NATURE GENETICS (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Distinct Neuroblastoma-associated Alterations of PHOX2B Impair Sympathetic Neuronal Differentiation in Zebrafish Models
Desheng Pei et al.
PLOS GENETICS (2013)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer
Manickam Janakiraman et al.
CANCER RESEARCH (2010)
ATR and ATM differently regulate WRN to prevent DSBs at stalled replication forks and promote replication fork recovery
Francesca Ammazzalorso et al.
EMBO JOURNAL (2010)
KEGG for representation and analysis of molecular networks involving diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2010)
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Helena Caren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Caren et al.
BIOCHEMICAL JOURNAL (2008)
28 years of high-dose therapy and SCT for neuroblastoma in Europe:: lessons from more than 4000 procedures
R. Ladenstein et al.
BONE MARROW TRANSPLANTATION (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Germline PHOX2B mutation in hereditary neuroblastoma
YP Mosse et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Share Paper
